CHINARES PHARMA (03320): KPC Pharmaceuticals, Inc.'s net profit for the first three quarters was 323 million yuan, a decrease of 35.76% year-on-year.
China Resources Pharmaceuticals (03320) announced the performance of Kun Medicine Group for the nine months ended September 30, 2025, with a total operating income...
CHINARES PHARMA (03320) released the performance of KPC Pharmaceuticals, Inc. for the nine months ending September 30, 2025, with a total operating revenue of 4.751 billion RMB, a decrease of 18.08% year-on-year; net profit of 323 million RMB, a decrease of 35.76% year-on-year.
Related Articles
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support
US Stock Market Move | Teladoc Health (TDOC.US) rises more than 9% after receiving a target price increase from Bank of America.
US Stock Market Move | Alphabet Inc. Class C (GOOGL.US) rose nearly 3%, deeply binding with Anthropic to build a computational moat.
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support
US Stock Market Move | Teladoc Health (TDOC.US) rises more than 9% after receiving a target price increase from Bank of America.
US Stock Market Move | Alphabet Inc. Class C (GOOGL.US) rose nearly 3%, deeply binding with Anthropic to build a computational moat.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
